Which has higher earnings & valuation, MDLN or ALC?

Medline has higher revenue and earnings than Alcon. Medline is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medline $28.43B 1.58 $1.16B $0.79 43.37 Alcon $10.40B 3.50 $980M $1.31 56.18

Is MDLN or ALC more profitable?

Alcon has a net margin of 5.92% compared to Medline's net margin of 0.00%. Alcon's return on equity of 7.29% beat Medline's return on equity. Company Net Margins Return on Equity Return on Assets Medline N/A N/A N/A Alcon 5.92% 7.29% 5.09%

Does the media favor MDLN or ALC?

In the previous week, Medline had 15 more articles in the media than Alcon. MarketBeat recorded 16 mentions for Medline and 1 mentions for Alcon. Alcon's average media sentiment score of 0.59 beat Medline's score of 0.21 indicating that Alcon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medline 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Alcon 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor WST or MDLN?

In the previous week, West Pharmaceutical Services had 2 more articles in the media than Medline. MarketBeat recorded 18 mentions for West Pharmaceutical Services and 16 mentions for Medline. West Pharmaceutical Services' average media sentiment score of 1.59 beat Medline's score of 0.21 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 18 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medline 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher earnings and valuation, SOLV or MDLN?

Solventum has higher earnings, but lower revenue than Medline. Solventum is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solventum $8.31B 1.84 $1.56B $8.18 10.96 Medline $28.43B 1.58 $1.16B $0.79 43.37

Is SOLV or MDLN more profitable?

Solventum has a net margin of 17.26% compared to Medline's net margin of 0.00%. Solventum's return on equity of 25.09% beat Medline's return on equity. Company Net Margins Return on Equity Return on Assets Solventum 17.26% 25.09% 8.78% Medline N/A N/A N/A

Does the media prefer SOLV or MDLN?

In the previous week, Medline had 12 more articles in the media than Solventum. MarketBeat recorded 16 mentions for Medline and 4 mentions for Solventum. Solventum's average media sentiment score of 0.91 beat Medline's score of 0.21 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medline 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher valuation and earnings, MDLN or COO?

Medline has higher revenue and earnings than Cooper Companies. Medline is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medline $28.43B 1.58 $1.16B $0.79 43.37 Cooper Companies $4.09B 3.63 $374.90M $1.18 64.59

Does the media refer more to MDLN or COO?

In the previous week, Cooper Companies had 16 more articles in the media than Medline. MarketBeat recorded 32 mentions for Cooper Companies and 16 mentions for Medline. Cooper Companies' average media sentiment score of 0.97 beat Medline's score of 0.21 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medline 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Cooper Companies 20 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Which has higher valuation & earnings, MDLN or ALGN?

Medline has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medline $28.43B 1.58 $1.16B $0.79 43.37 Align Technology $4.03B 2.89 $410.35M $5.75 28.27

Does the media favor MDLN or ALGN?

In the previous week, Medline had 4 more articles in the media than Align Technology. MarketBeat recorded 16 mentions for Medline and 12 mentions for Align Technology. Align Technology's average media sentiment score of 1.18 beat Medline's score of 0.21 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medline 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Align Technology 9 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Medline (MDLN) Competitors

$34.26 0.00 (0.00%)

As of 08/21/2026 04:00 PM Eastern

Compare

MDLN vs. ALC, WST, SOLV, COO, and ALGN

Should you buy Medline stock or one of its competitors? Medline's main competitors and comparable companies include Alcon (ALC), West Pharmaceutical Services (WST), Solventum (SOLV), Cooper Companies (COO), and Align Technology (ALGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Medline compare to Alcon?

Medline (NASDAQ:MDLN) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Medline presently has a consensus target price of $47.42, indicating a potential upside of 38.42%. Alcon has a consensus target price of $84.96, indicating a potential upside of 15.46%. Given Medline's stronger consensus rating and higher possible upside, equities analysts plainly believe Medline is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

53.9% of Alcon shares are owned by institutional investors. 0.8% of Medline shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Alcon has a net margin of 5.92% compared to Medline's net margin of 0.00%. Alcon's return on equity of 7.29% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
Alcon	5.92%	7.29%	5.09%

In the previous week, Medline had 15 more articles in the media than Alcon. MarketBeat recorded 16 mentions for Medline and 1 mentions for Alcon. Alcon's average media sentiment score of 0.59 beat Medline's score of 0.21 indicating that Alcon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Alcon	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medline has higher revenue and earnings than Alcon. Medline is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.58	$1.16B	$0.79	43.37
Alcon	$10.40B	3.50	$980M	$1.31	56.18

Summary

Medline and Alcon tied by winning 8 of the 16 factors compared between the two stocks.

How does Medline compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends.

West Pharmaceutical Services currently has a consensus target price of $368.08, indicating a potential upside of 4.29%. Medline has a consensus target price of $47.42, indicating a potential upside of 38.42%. Given Medline's higher probable upside, analysts plainly believe Medline is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83

93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 0.8% of Medline shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, West Pharmaceutical Services had 2 more articles in the media than Medline. MarketBeat recorded 18 mentions for West Pharmaceutical Services and 16 mentions for Medline. West Pharmaceutical Services' average media sentiment score of 1.59 beat Medline's score of 0.21 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	18 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medline	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

West Pharmaceutical Services has a net margin of 16.98% compared to Medline's net margin of 0.00%. West Pharmaceutical Services' return on equity of 20.11% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.98%	20.11%	14.83%
Medline	N/A	N/A	N/A

Medline has higher revenue and earnings than West Pharmaceutical Services. Medline is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.08	$493.70M	$7.81	45.19
Medline	$28.43B	1.58	$1.16B	$0.79	43.37

Summary

West Pharmaceutical Services beats Medline on 10 of the 16 factors compared between the two stocks.

How does Medline compare to Solventum?

Solventum (NYSE:SOLV) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, Medline had 12 more articles in the media than Solventum. MarketBeat recorded 16 mentions for Medline and 4 mentions for Solventum. Solventum's average media sentiment score of 0.91 beat Medline's score of 0.21 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medline	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Solventum has a net margin of 17.26% compared to Medline's net margin of 0.00%. Solventum's return on equity of 25.09% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.26%	25.09%	8.78%
Medline	N/A	N/A	N/A

Solventum presently has a consensus price target of $91.64, indicating a potential upside of 2.23%. Medline has a consensus price target of $47.42, indicating a potential upside of 38.42%. Given Medline's stronger consensus rating and higher possible upside, analysts clearly believe Medline is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.54
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83

Solventum has higher earnings, but lower revenue than Medline. Solventum is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.31B	1.84	$1.56B	$8.18	10.96
Medline	$28.43B	1.58	$1.16B	$0.79	43.37

Summary

Solventum and Medline tied by winning 7 of the 14 factors compared between the two stocks.

How does Medline compare to Cooper Companies?

Medline (NASDAQ:MDLN) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Medline has higher revenue and earnings than Cooper Companies. Medline is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.58	$1.16B	$0.79	43.37
Cooper Companies	$4.09B	3.63	$374.90M	$1.18	64.59

Medline presently has a consensus price target of $47.42, indicating a potential upside of 38.42%. Cooper Companies has a consensus price target of $81.64, indicating a potential upside of 7.11%. Given Medline's stronger consensus rating and higher possible upside, analysts plainly believe Medline is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

In the previous week, Cooper Companies had 16 more articles in the media than Medline. MarketBeat recorded 32 mentions for Cooper Companies and 16 mentions for Medline. Cooper Companies' average media sentiment score of 0.97 beat Medline's score of 0.21 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Cooper Companies	20 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Cooper Companies has a net margin of 5.57% compared to Medline's net margin of 0.00%. Cooper Companies' return on equity of 10.88% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
Cooper Companies	5.57%	10.88%	7.27%

24.4% of Cooper Companies shares are owned by institutional investors. 0.8% of Medline shares are owned by company insiders. Comparatively, 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Cooper Companies beats Medline on 10 of the 16 factors compared between the two stocks.

How does Medline compare to Align Technology?

Medline (NASDAQ:MDLN) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

Medline currently has a consensus target price of $47.42, indicating a potential upside of 38.42%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 26.95%. Given Medline's stronger consensus rating and higher possible upside, research analysts plainly believe Medline is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Medline had 4 more articles in the media than Align Technology. MarketBeat recorded 16 mentions for Medline and 12 mentions for Align Technology. Align Technology's average media sentiment score of 1.18 beat Medline's score of 0.21 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Align Technology	9 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medline has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.58	$1.16B	$0.79	43.37
Align Technology	$4.03B	2.89	$410.35M	$5.75	28.27

Align Technology has a net margin of 9.99% compared to Medline's net margin of 0.00%. Align Technology's return on equity of 15.86% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
Align Technology	9.99%	15.86%	10.32%

88.4% of Align Technology shares are held by institutional investors. 0.8% of Medline shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Medline beats Align Technology on 9 of the 16 factors compared between the two stocks.

Get Medline News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDLN vs. The Competition

Export

Metric	Medline	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$45.04B	$5.88B	$7.32B	$12.82B
Dividend Yield	N/A	1.74%	2.54%	10.78%
P/E Ratio	43.37	26.54	272.90	24.25
Price / Sales	1.58	70.90	632.64	97.63
Price / Cash	20.20	33.71	29.03	36.90
Price / Book	2.33	6.22	11.25	6.42
Net Income	$1.16B	$149.90M	$3.47B	$348.89M
7 Day Performance	-1.78%	1.16%	2.33%	0.57%
1 Month Performance	-11.59%	9.21%	7.72%	4.90%
1 Year Performance	N/A	8.07%	25.22%	17.06%

Medline Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDLN Medline	3.8393 of 5 stars	$34.26 flat	$47.42 +38.4%	N/A	$45.04B	$28.43B	43.37	45,000
ALC Alcon	3.2165 of 5 stars	$73.96 -0.4%	$84.63 +14.4%	-10.3%	$36.57B	$10.40B	56.44	25,942
WST West Pharmaceutical Services	4.0619 of 5 stars	$356.92 +1.2%	$368.08 +3.1%	+42.6%	$25.08B	$3.07B	45.63	10,800	Positive News
SOLV Solventum	2.7309 of 5 stars	$88.32 +0.6%	$91.64 +3.8%	+22.0%	$14.97B	$8.33B	10.75	20,000	Analyst Downgrade
COO Cooper Companies	2.7913 of 5 stars	$76.46 -0.4%	$81.64 +6.8%	+1.3%	$14.90B	$4.09B	64.76	15,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDLN) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medline (MDLN) Competitors

MDLN vs. ALC, WST, SOLV, COO, and ALGN

How does Medline compare to Alcon?

Summary

How does Medline compare to West Pharmaceutical Services?

Summary

How does Medline compare to Solventum?

Summary

How does Medline compare to Cooper Companies?

Summary

How does Medline compare to Align Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDLN vs. The Competition

Medline Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medline (MDLN) Competitors

MDLN vs. ALC, WST, SOLV, COO, and ALGN

How does Medline compare to Alcon?

Do analysts prefer MDLN or ALC?

Do institutionals and insiders believe in MDLN or ALC?

Is MDLN or ALC more profitable?

Does the media favor MDLN or ALC?

Which has higher earnings & valuation, MDLN or ALC?

Summary

How does Medline compare to West Pharmaceutical Services?

Do analysts recommend WST or MDLN?

Do insiders & institutionals have more ownership in WST or MDLN?

Does the media favor WST or MDLN?

Is WST or MDLN more profitable?

Which has better valuation & earnings, WST or MDLN?

Summary

How does Medline compare to Solventum?

Does the media prefer SOLV or MDLN?

Is SOLV or MDLN more profitable?

Do analysts recommend SOLV or MDLN?

Which has higher earnings and valuation, SOLV or MDLN?

Summary

How does Medline compare to Cooper Companies?

Which has higher valuation and earnings, MDLN or COO?

Do analysts prefer MDLN or COO?

Does the media refer more to MDLN or COO?

Is MDLN or COO more profitable?

Do insiders & institutionals believe in MDLN or COO?

Summary

How does Medline compare to Align Technology?

Do analysts rate MDLN or ALGN?

Does the media favor MDLN or ALGN?

Which has higher valuation & earnings, MDLN or ALGN?

Is MDLN or ALGN more profitable?

Do insiders and institutionals believe in MDLN or ALGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDLN vs. The Competition

Medline Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools